Even though there is no strong evidence that GFAP correlates with kidney parameters or disease activity in autoimmune diseases with renal involvement, GFAP’s presence in non-CNS tissues, including the kidneys, suggests it could reflect systemic inflammation affecting the kidneys, as seen in conditions like AAV. Here, GFAP is linked to autoimmune disease.